Akiko Maekawa

2.6k citations
23 papers · 2.1k indexed · h-index 20

Akiko Maekawa

22 papers receiving 2.0k citations

Peers

Akiko Maekawa
Comparison fields: 5 of 89
  • Physiology 999
  • Immunology 745
  • Molecular Biology 585
  • Immunology and Allergy 338
  • Pulmonary and Respiratory Medicine 295
Replace Luzheng Xue with:
Luzheng Xue United Kingdom
Rainer Spanbroek Germany
Jean Michel Mencia‐Huerta France
Linhua Pang United Kingdom
Miguel A. Vega Spain
Kazuko Saeki Japan
Alejandro Vazquez‐Tello Canada
Osamu Kaminuma Japan
Daiji Sakata Japan
Lisa A. Madge United States
Akiko Maekawa relative to Luzheng Xue United Kingdom Luzheng Xue's profile →
Citations per field
00.5×1.5×
Luzheng Xue · 1×
Citations per year

Countries citing papers authored by Akiko Maekawa

Since Specialization
Citations

This map shows the geographic impact of Akiko Maekawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Maekawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Maekawa more than expected).

Fields of papers citing papers by Akiko Maekawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Maekawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Maekawa. The network helps show where Akiko Maekawa may publish in the future.

Co-authorship network of co-authors of Akiko Maekawa

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Maekawa. A scholar is included among the top collaborators of Akiko Maekawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Maekawa. Akiko Maekawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 84
3 147
4 32
5 4
6 201
7 65
8 191
9 81
10
Determination of paroxetine in human saliva by reversed-phase high-performance liquid chromatography with UV detection.
1
11 34
12 127
13 43
14 127
15 64
16 118
17 150
18 129
19 55
20 135

About Akiko Maekawa

Akiko Maekawa is a scholar working on Immunology and Allergy, Physiology and Microbiology, having authored 23 papers that have together received 2.1k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (15 papers), Mast cells and histamine (7 papers) and Allergic Rhinitis and Sensitization (6 papers). The work is most often cited by research in Immunology and Allergy (338 citations), Physiology (999 citations) and Immunology (745 citations). Akiko Maekawa has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Yoshihide Kanaoka, K. Frank Austen, K. Frank Austen, Joshua A. Boyce, Wei Xing, Bing Lam, Daniel S. Friend, Nora A. Barrett, Barbara Balestrieri and John F. Penrose. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026